Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Oral anticoagulants are crucial for stroke prevention in atrial fibrillation.
• Increased bleeding risk is a primary limitation of oral anticoagulant therapy.
• Optimal use of anticoagulation is essential for managing atrial fibrillation effectively.

Purpose of the Study:

• To review literature on barriers to optimal oral anticoagulation therapy in atrial fibrillation.
• To describe the clinical and economic burdens associated with these barriers.
• To evaluate how new oral anticoagulants might address existing challenges.

Main Methods:

• Literature review of medical publications from 2000 to 2011.
• Synthesis of findings on barriers, burdens, and new anticoagulant therapies.
• Analysis of the potential impact of novel oral anticoagulants on therapy optimization.

Main Results:

• Identified significant barriers to optimal oral anticoagulation therapy.
• Documented clinical and economic consequences of suboptimal anticoagulation.
• Highlighted the potential of new oral anticoagulants to mitigate some identified barriers.

Conclusions:

• Barriers to optimal oral anticoagulation therapy in atrial fibrillation lead to substantial clinical and economic burdens.
• Newer oral anticoagulants show promise in addressing some of these barriers, potentially improving stroke prevention.
• Further research and implementation strategies are needed to ensure optimal use of anticoagulation therapy in atrial fibrillation management.